Both in Biotechnology
Monte Rosa Therapeutics vs MeiraGTx Holdings
Over the past year GLUE returned −13.8% and MGTX returned +9.0%; their daily moves had a correlation of 0.27.
GLUE −13.8% MGTX +9.0%Growth of $1, one year, split-adjusted
| Metric | GLUE | MGTX |
|---|---|---|
| Price | $10.41 | $9.52 |
| Market cap | $888.1M | $914.3M |
| Today | −2.07% | +2.15% |
| 1 month | +1.4% | −12.8% |
| 6 months | −46.2% | −2.4% |
| Year to date | −33.6% | +19.7% |
| 1 year | −19.0% | +4.8% |
| Revenue growth (YoY) | −61.3% | +8608.6% |
| Gross margin | 100.0% | 97.8% |
| Net margin | −483.9% | 50.0% |
| P/E (TTM) | — | 11.6× |
| Price / sales | 30.9× | 2.3× |
| Net cash | $621.1M | $21.8M |
| Dividend yield | — | — |
| Volatility (60d) | 52.5% | 47.5% |
| Short % of float | 41.9% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).